News

Invisicare is the core technology in Skinvisible’s portfolio of products. Skinvisible licenses it products on an exclusive basis to companies seeking new products in the areas such as

The new label with an updated SmPC will be implemented after the European Commission has approved the CHMP recommendation. The pivotal trial published in 2005 where a combination

Pfizer said that the agreement is the final step in the AMC procurement process which is administered by the United Nations Children’s Fund (UNICEF) and supported by Global

The acquisition for an undisclosed sum, becomes effective March 26, 2010 and is expected to increase the earnings of Nuplex’s specialties business by more than 15% for the

The next-generation primary care record under development by Mayo Clinic and VitalHealth Software expects to create simplicity at the point of care while contributing to quality of care

The acquisition provides Abbott with products and expertise to build its position in laboratory informatics, an emerging and rapidly growing field focused on helping to manage the increasing

The latest contract, worth GBP6m, extends the original $47.8m agreement, signed in March 2008, to 2016. It expands the services offered and includes new HP hardware and infrastructure

Pharmaceutical brands build websites primarily to drive drug adoption. Most importantly, the brands need to know which content areas drive the desired behaviors and which content areas do

Roche said that the CHMP positive opinion clears the way for EU approval and means that this group of patients may soon be able to benefit from earlier